AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| 1 |
Applied Materials
AMAT
|
+$1.11B |
| 2 |
Walt Disney
DIS
|
+$920M |
| 3 |
ILOW
AB International Low Volatility Equity ETF
ILOW
|
+$784M |
| 4 |
Broadcom
AVGO
|
+$771M |
| 5 |
United Rentals
URI
|
+$751M |
Top Sells
| 1 |
Intuitive Surgical
ISRG
|
+$1.19B |
| 2 |
NVIDIA
NVDA
|
+$998M |
| 3 |
Edwards Lifesciences
EW
|
+$881M |
| 4 |
CrowdStrike
CRWD
|
+$663M |
| 5 |
Adobe
ADBE
|
+$599M |
Sector Composition
| 1 | Technology | 28.34% |
| 2 | Healthcare | 15.32% |
| 3 | Consumer Discretionary | 10.78% |
| 4 | Financials | 9.64% |
| 5 | Communication Services | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3026
OptimizeRx
OPRX
$340M
| $209K | ﹤0.01% |
27,050
| – | – |
|
|
DCBO
3027
Docebo
DCBO
$913M
| $209K | ﹤0.01% |
3,494
+233
| +7% | +$13.9K |
|
3028
Applied Optoelectronics
AAOI
$1.47B
| $208K | ﹤0.01% |
14,510
-22,198
| -60% | -$318K |
|
3029
Park Aerospace
PKE
$379M
| $208K | ﹤0.01% |
15,932
| – | – |
|
|
MGIC
3030
Magic Software Enterprises
MGIC
$987M
| $207K | ﹤0.01% |
4,680
| – | – |
|
3031
Willis Lease Finance
WLFC
$1.14B
| $207K | ﹤0.01% |
+1,390
| New | +$207K |
|
3032
Aquestive Therapeutics
AQST
$606M
| $206K | ﹤0.01% |
41,290
+10
| +0% | +$50 |
|
3033
Oil-Dri
ODC
$955M
| $205K | ﹤0.01% |
+5,940
| New | +$205K |
|
3034
Corbus Pharmaceuticals
CRBP
$121M
| $205K | ﹤0.01% |
9,920
+2,710
| +38% | +$55.9K |
|
3035
Entrada Therapeutics
TRDA
$201M
| $204K | ﹤0.01% |
12,770
+2,550
| +25% | +$40.7K |
|
3036
Granite Ridge Resources
GRNT
$689M
| $204K | ﹤0.01% |
34,300
-3,720
| -10% | -$22.1K |
|
3037
Bowman Consulting
BWMN
$713M
| $204K | ﹤0.01% |
8,460
+570
| +7% | +$13.7K |
|
3038
Bioventus
BVS
$482M
| $199K | ﹤0.01% |
16,670
+5,210
| +45% | +$62.3K |
|
3039
Coherus Oncology, Inc. Common Stock
CHRS
$159M
| $196K | ﹤0.01% |
188,410
| – | – |
|
3040
GrowGeneration
GRWG
$92M
| $195K | ﹤0.01% |
91,770
| – | – |
|
|
GRAL
3041
GRAIL, Inc. Common Stock
GRAL
$1.38B
| $195K | ﹤0.01% |
14,169
-888
| -6% | -$12.2K |
|
3042
Absci
ABSI
$375M
| $195K | ﹤0.01% |
50,970
-510
| -1% | -$1.95K |
|
3043
Sigma Lithium
SGML
$695M
| $194K | ﹤0.01% |
+15,680
| New | +$194K |
|
3044
E.W. Scripps
SSP
$264M
| $193K | ﹤0.01% |
86,047
| – | – |
|
3045
Pure Cycle
PCYO
$264M
| $190K | ﹤0.01% |
17,620
+770
| +5% | +$8.29K |
|
3046
Ooma
OOMA
$355M
| $189K | ﹤0.01% |
16,590
| – | – |
|
3047
Kodiak Sciences
KOD
$517M
| $187K | ﹤0.01% |
71,470
| – | – |
|
3048
Monte Rosa Therapeutics
GLUE
$296M
| $186K | ﹤0.01% |
35,140
+2,360
| +7% | +$12.5K |
|
|
CRON
3049
Cronos Group
CRON
$950M
| $185K | ﹤0.01% |
84,598
| – | – |
|
3050
Sight Sciences
SGHT
$193M
| $184K | ﹤0.01% |
29,280
+1,820
| +7% | +$11.5K |
|